Marc Olivier Heuschkel

Dr. Marc Olivier Heuschkel

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2021 in IEEE Transactions on Biomedical Circuits and Systems
Verified
Journal Article
Open access
RWRick Wertenbroek
Rick Wertenbroek
YTYann Thoma
Yann Thoma
FMFlavio Maurizio Mor
Flavio Maurizio Mor
SGSara Grassi
Sara Grassi
Marc Olivier HeuschkelMarc Olivier Heuschkel
Marc Olivier Heuschkel
LSLuc Stoppini
Luc Stoppini
In this paper we present SpikeOnChip, a custom embedded platform for neuronal activity recording and online analysis. The SpikeOnChip platform was developed in the context of automated drug testing and toxicology assessments on neural tissue made from human induced pluripotent stem cells. The system was developed with the following goals: to be small, autonomous and low power, to handle micro-electrode arrays with up to 256 electrodes, to reduce the amount of data generated from the recording, to be able to do computation during acquisition, and to be customizable. This led to the choice of a Field Programmable Gate Array System-On-Chip platform. This paper focuses on the embedded system for acquisition and processing with key features being the ability to record electrophysiological signals from multiple electrodes, detect biological activity on all channels online for recording, and do frequency domain spectral energy analysis online on all channels during acquisition. Development methodologies are also presented. The platform is finally illustrated in a concrete experiment with bicuculline being administered to grown human neural tissue through microfluidics, resulting in measurable effects in the spike recordings and activity. The presented platform provides a valuable new experimental instrument that can be further extended thanks to the programmable hardware and software.

1 January 2018 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
Marc Olivier HeuschkelMarc Olivier Heuschkel
Marc Olivier Heuschkel
FMFlavio M. Mor
Flavio M. Mor
LSLuc Stoppini
Luc Stoppini
Human 3D Engineered Neural Tissue (ENT) made of neurons derived from human induced pluripotent stem cells (hiPSC) are among the most promising tools for the next decade in drug discovery and neurotoxicology. It represents a cheaper, faster and more ethical alternative to in vivo animal testing that will likely close the bridge between in vitro animal models and human clinical trials. MEA recordings of spontaneous activity in ENTs offer a non-invasive, real-time and long-term assessment of compounds' effects. However, the use of ENTs (diameter 0.5mm to 1mm) on MicroElectrode Arrays (MEA) involves a series of constraints, such as drastically limited diffusion of oxygen and nutrients due to the lack of vascularization. As a consequence, ENTs are extremely sensitive to experimental conditions and require adequately designed MEA devices that allow the maintenance of an air-liquid interface around ENTs during culture and recording. Past results using 3D glass tip-shaped electrode MEA devices (Heuschkel et al 2002) have demonstrated advantages in the use of 3D versus 2D electrode geometries when monitoring acute brain slices from rodents. In order to improve currently available polyimide-based 2D MEA devices used in combination with ENTs at our laboratory, novel 3D electrode arrays that present electrodes protruding from the porous polyimide substrate have been developed. The manufactured MEA devices are composed of 4 independent wells, where the bottom of each well is made of a porous polyimide membrane (thickness of 8µm) that integrates 8 platinum recording electrodes arranged on a 200µm grid and 2 large reference electrodes. Planar 2D electrodes do have the following characteristics: a circular shape, a diameter of 30µm, and are coated with black platinum material providing low impedance (20-30kΩ @ 1kHz). Based on the same electrode arrangement, the novel 3D electrodes have a square pyramidal or a square truncated pyramidal shape, which are the simplest shapes that can be achieve using microfabrication processes. Obtained electrode heights are 25µm and 35µm for pyramidal electrodes and 25µm for truncated pyramidal electrodes. Resulting platinum electrode impedance is in the range of 300-800kΩ @ 1kHz depending on shape and dimensions of the 3D electrodes. Similar to results from 3D tip-shaped glass electrode arrays, recordings of spontaneous activity from ENTs show that larger signal amplitudes can be recorded with the 3D pyramidal polyimide MEA devices. Furthermore, the recordings from 3D electrodes display a variety of more complex signal shapes (multiple waves) that are less present in planar electrode MEA devices, which suggests that the 3D electrodes configuration reduces the distance between the electrodes and the active cells and neurites within the tissue by slight penetration into the tissue. In conclusion, a novel stand-alone MEA device specifically designed for medium-throughput testing of human 3D engineered neural tissue based on 3D porous polyimide MEA devices has been built and characterized.

31 July 2026 in Micromachines
Verified
Journal Article
Open access
PDF file
DADoha Abdelrahman
Doha Abdelrahman
ASAlain Savary
Alain Savary
BFBernard Feuillard
Bernard Feuillard
Marc Olivier HeuschkelMarc Olivier Heuschkel
Marc Olivier Heuschkel
DPDario Principi
Dario Principi
CBChristophe Besson
Christophe Besson
Achieving precise, untethered manipulation at the millimeter scale remains a fundamental challenge in minimally invasive medicine. Magnetic milligrippers have emerged as promising untethered tools for grasping, transporting, and releasing objects in confined anatomical environments, yet most existing rigid designs rely on multi-component assemblies with dedicated hinges or joints that require complex fabrication processes. Here, we present a simple, cost-effective rigid magnetic milligripper based on a folded titanium structure with two inclined permanent magnets. Actuated by a three-axis Helmholtz–Maxwell coil system, it enables orientation and translation control, as well as reversible opening. The actuation platform is coupled to a joystick-based control interface, allowing intuitive, real-time steering and opening of the milligripper by a single operator. The design is established with an analytical magnetic dipole model and validated through both finite-element simulations and experimental characterization, which together confirm reproducible, fully elastic operation across the investigated actuation range. The strong agreement between analytical, numerical, and experimental results establishes this architecture as a mechanically robust and scalable proof-of-concept platform for magnetic micromanipulation, with direct relevance to future minimally invasive biomedical applications.

18 November 2026 in bioRxiv
Verified
Preprint
Open access
FFFabien Friscourt
Fabien Friscourt
LSLuc Stoppini
Luc Stoppini
SSShaginth Sivakumar
Shaginth Sivakumar
Marc Olivier HeuschkelMarc Olivier Heuschkel
Marc Olivier Heuschkel
LNLaetitia Nikles
Laetitia Nikles
Adrien RouxAdrien Roux
Adrien Roux
Objective: Conventional microelectrode arrays (MEAs) are suboptimal for long-term electrophysiology of three-dimensional (3D) excitable tissues, as limited oxygenation, nutrient diffusion, and tissue-electrode coupling compromise recording stability. Air-liquid interface (ALI) culture mitigates these constraints, but existing ALI MEA platforms are limited in channel count, flexibility, and compatibility with commercial multichannel acquisition systems. We developed and comprehensively characterized a next-generation ALI MEA for standardized, long-term recordings across multiple 3D excitable tissue models. Approach: The novel ALI MEA60 is composed of a porous polyimide membrane that integrates an array of 60 thin film microelectrodes (59 recording, one reference) and a basal perfusion chamber with Luer-lock connectors for controlled medium exchange and pharmacological wash-in/wash-out. It is compatible with the MEA2100-Mini data acquisition system (Multi Channel Systems). We characterized electrode impedance and noise across 41 ALI MEA60 devices, assessed 60-day stability with human iPSC-derived neural spheroids (N = 7 MEAs, 121 recordings) using a standardized longitudinal framework and linear mixed-effects models, and evaluated its versatility through pharmacological assays and recordings from human neural spheroids, brain organoids, ex vivo brain slices, and cardiac organoids. Main results: The platform showed reproducible electrical performance (median impedance 56 kOhms; at 1 kHz) and low noise (approx. 5uV Root Mean Square (RMS) in saline, 10-20 uV in medium), resolving spikes and local field potentials simultaneously. Recording remained stable for at least 60 days, with a stable noise floor and ~85% persistence of initial functional channels. Neural spheroids reproduced the standard qualitative signatures to gabazine, 4-aminopyridine (4-AP), and 6-Cyano-7-nitroquinoxaline-2,3-dione/D-2-amino-5-phosphonovalerate (CNQX/D-AP5), while cardiac organoids showed the expected beta-adrenergic response to isoproterenol. The ALI MEA60 can similarly record signals from human brain slices and organoids without hardware modification. Significance: The ALI MEA60 combines ALI culture, chronic recording stability, standardized pharmacological testing and cross-tissue compatibility in a single ready-to-use platform. It also establishes a reproducible framework for benchmarking long-term electrophysiological performance, thereby supporting disease modelling, drug discovery, organ-on-chip technologies and future chronic 3D electrophysiology systems. Keywords: microelectrode array (MEA); air-liquid interface (ALI); 3D excitable tissues; neural spheroids; cardiac organoids; chronic electrophysiology.

10 July 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
DLDavid G. Litvin
David G. Litvin
ABAlexia Boizot
Alexia Boizot
ACAndrea Corna
Andrea Corna
ANAurélie Navarro
Aurélie Navarro
JKJosiane Keller
Josiane Keller
DGDiego Ghezzi
Diego Ghezzi
Retinal remodeling occurs in both retinitis pigmentosa and age-related macular degeneration. However, it is still unknown whether spared retinal circuits are also functionally altered. Functional changes have been observed in animal models of retinitis pigmentosa, including the emergence of bursting oscillatory activity in retinal ganglion cells. Yet, comparable oscillatory activity, or other functional alterations, has not been demonstrated in patients. To address this gap, here we report a non-invasive corneal neurotechnology measuring in-vivo resting-state electroretinography and analyzing its frequency content and temporal characteristics to identify biomarkers of functional remodeling. We document that retinal remodeling induces bursting oscillatory activity in-vivo in retinitis pigmentosa mouse models and translate these results to patients. Moreover, we showed in mice that bursting oscillatory activity can be pharmacologically modulated in-vivo. Furthermore, reducing this oscillatory activity increases retinal excitability to electrical stimulation. These results are crucial for a better understanding of retinal degeneration and contribute to sight restoration efforts.